Insider Transactions in Q1 2024 at Science 37 Holdings, Inc. (SNCE)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 12
2024
|
Thermo Fisher Scientific Inc. |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
1,737,980
-100.0%
|
$8,689,900
$5.75 P/Share
|
|
Mar 12
2024
|
Redmile Group, LLC |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
1,017,203
-100.0%
|
$5,086,015
$5.75 P/Share
|
|
Mar 12
2024
|
Robert C. Faulkner |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
26,791
-100.0%
|
$133,955
$5.75 P/Share
|
|
Mar 12
2024
|
David Coman Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
30,781
-100.0%
|
$153,905
$5.75 P/Share
|
|
Mar 12
2024
|
David Coman Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
53,834
-100.0%
|
$269,170
$5.75 P/Share
|
|
Mar 12
2024
|
John W Hubbard |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
2,050
-100.0%
|
$10,250
$5.75 P/Share
|
|
Mar 12
2024
|
Emily Rollins |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
2,050
-100.0%
|
$10,250
$5.75 P/Share
|
|
Mar 12
2024
|
Neil Tiwari |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
2,050
-100.0%
|
$10,250
$5.75 P/Share
|
|
Mar 12
2024
|
Paul Von Autenried |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
2,302
-100.0%
|
$11,510
$5.75 P/Share
|
|
Mar 12
2024
|
Christine A Pellizzari Chief Legal and HR Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
35,115
-100.0%
|
$175,575
$5.75 P/Share
|
|
Mar 12
2024
|
Christine A Pellizzari Chief Legal and HR Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
14,579
-100.0%
|
$72,895
$5.75 P/Share
|
|
Mar 12
2024
|
Mike Zaranek Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
22,212
-100.0%
|
$111,060
$5.75 P/Share
|
|
Mar 12
2024
|
Mike Zaranek Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
9,070
-100.0%
|
$45,350
$5.75 P/Share
|
|
Mar 12
2024
|
Darcy Forman Chief Delivery Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
24,644
-100.0%
|
$123,220
$5.75 P/Share
|
|
Mar 12
2024
|
Darcy Forman Chief Delivery Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
15,753
-100.0%
|
$78,765
$5.75 P/Share
|
|
Mar 12
2024
|
Jonathan Cotliar Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,864
-100.0%
|
$64,320
$5.75 P/Share
|
|
Mar 12
2024
|
Jonathan Cotliar Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
41,891
-100.0%
|
$209,455
$5.75 P/Share
|
|
Mar 12
2024
|
Michael Shipton Chief Commercial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
9,247
-100.0%
|
$46,235
$5.75 P/Share
|
|
Mar 10
2024
|
Michael Shipton Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,006
-24.53%
|
$15,030
$5.73 P/Share
|
|
Mar 10
2024
|
Michael Shipton Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,713
+41.56%
|
-
|